| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/17/2002 | EP1196409A2 Respiratory syncytial virus replication inhibitors |
| 04/17/2002 | EP1196408A1 Respiratory syncytial virus replication inhibitors |
| 04/17/2002 | EP1196407A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors |
| 04/17/2002 | EP1196406A1 Amino ceramide-like compounds and therapeutic methods of use |
| 04/17/2002 | EP1196404A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 04/17/2002 | EP1196403A1 Antipsychotic cyclic n-aralkyl amines |
| 04/17/2002 | EP1196400A1 Amino-alkyl derivatives |
| 04/17/2002 | EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 04/17/2002 | EP1196396A1 Conjugates of sodium channel blockers and methods of using the same |
| 04/17/2002 | EP1196395A1 Cyclized amino acid derivatives |
| 04/17/2002 | EP1196394A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 04/17/2002 | EP1196392A1 6-carboxyphenyldihydropyridazinone derivatives and use thereof |
| 04/17/2002 | EP1196391A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 04/17/2002 | EP1196390A2 Pyrazole compositions useful as inhibitors of erk |
| 04/17/2002 | EP1196389A1 N-heterocyclic derivatives with neuronal activity |
| 04/17/2002 | EP1196388A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 04/17/2002 | EP1196387A1 Azo amino acid derivatives for the treatment of neurological diseases |
| 04/17/2002 | EP1196386A2 N-substituted glycine derivatives |
| 04/17/2002 | EP1196385A1 Beta-amino acid derivatives for the treatment of neurological diseases |
| 04/17/2002 | EP1196384A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| 04/17/2002 | EP1196383A1 Process for preparing amlodipine benzenesulphonate |
| 04/17/2002 | EP1196381A2 Process for the preparation of n-(1,1-dimethylethyl)-4-((5'-ethoxy-4-cis-(2-(4-morfolino)ethoxy)-2'-oxospiro(cyclohexan-1,3'-(3h)indol)-1'(2'h)-yl)-sulfonyl)-3-methoxybenzamide and its salts |
| 04/17/2002 | EP1196380A2 Indoles and indazoles for the treatment of migraine |
| 04/17/2002 | EP1196379A2 INHIBITORS OF FACTOR Xa |
| 04/17/2002 | EP1196373A1 3-amino-2-benzyl-1-phenyl-propane derivatives |
| 04/17/2002 | EP1196371A1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
| 04/17/2002 | EP1196195A1 Nasogastric enteral formulations |
| 04/17/2002 | EP1196194A2 COMBINATION OF MTP INHIBITORS AND HMG-CoA REDUCTASE INHIBITORS AND THE USE THEREOF IN MEDICAMENTS |
| 04/17/2002 | EP1196190A1 Use of long-chain n-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of a medicament for the treatment of glycolipid storage diseases |
| 04/17/2002 | EP1196189A2 Multiple agent diabetes therapy |
| 04/17/2002 | EP1196181A1 Fat-binding polymers, optionally combined with lipase inhibitors |
| 04/17/2002 | EP1196180A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 04/17/2002 | EP1196179A2 Hyaluronic acid derivatives for the prevention and treatment of cutaneous scars |
| 04/17/2002 | EP1196177A2 Uses of ouabain and ouabain-like molecules in apoptosis related pathologies |
| 04/17/2002 | EP1196176A1 Use of beta-napthoquinone for making medicines having an inhibiting effect on the release of glutamate by the brain |
| 04/17/2002 | EP1196175A1 Pharmaceutical tablets |
| 04/17/2002 | EP1196174A1 Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis |
| 04/17/2002 | EP1196173A2 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof |
| 04/17/2002 | EP1196172A2 Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders |
| 04/17/2002 | EP1196171A2 Use of pyridoxin derivatives for the treatment of diabetes and related complications |
| 04/17/2002 | EP1196170A2 New use of a macrolide compound for treating neurodegenerative disorders |
| 04/17/2002 | EP1196169A1 Compounds having cytokine inhibitory activity |
| 04/17/2002 | EP1196168A2 Method of admistering an imidazole derivative to obtain analgesia |
| 04/17/2002 | EP1196167A1 Method of reducing neuronal injury or apoptosis |
| 04/17/2002 | EP1196166A1 Azetidine carboxamide derivatives for the treatment of cns disorders |
| 04/17/2002 | EP1196165A2 Azetidine compounds in cns and eye diseases |
| 04/17/2002 | EP1196164A2 Methods and compositions for regulating gut motility and food intake |
| 04/17/2002 | EP1196163A2 Methods of treating and/or suppressing weight gain |
| 04/17/2002 | EP1196162A1 Procyanidin oligomers for inhibiting matrix metalloproteinases and medicine having effective composition of same |
| 04/17/2002 | EP1196161A1 Selective inhibition of cyclooxygenase-2 |
| 04/17/2002 | EP1196160A1 A synergistic combination: gabapentin and pregabalin |
| 04/17/2002 | EP1196159A1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 04/17/2002 | EP1196158A1 Curcumin and curcuminoid inhibition of angiogenesis |
| 04/17/2002 | EP1196156A2 Transnasal anticonvulsive compositions and modulated process |
| 04/17/2002 | EP1196155A1 New use of compounds as antibacterial agents |
| 04/17/2002 | EP1196154A2 Inhibition of renal uptake of radiomolecules with a combination of lysine and arginine |
| 04/17/2002 | EP1196153A2 Process for the improvement of spermatozoa fertilization activity |
| 04/17/2002 | EP1196152A1 Use of cortisol antagonists in the treatment for heart failure |
| 04/17/2002 | EP1196151A1 Transdermal therapeutic system for administering a calcium antagonist |
| 04/17/2002 | EP1196149A1 BIODEGRADABLE POLY(ALKYLENE OXIDE)-POLY(p-DIOXANONE) BLOCK COPOLYMER SOLUBLE IN ORGANIC SOLVENTS, AND DRUG DELIVERY COMPOSITION COMPRISING SAME |
| 04/17/2002 | EP1196147A1 Oral liquid compositions |
| 04/17/2002 | EP1196145A1 Methods and apparatus for preparation of lipid vesicles |
| 04/17/2002 | EP1196135A1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 04/17/2002 | EP1196129A1 Method for scavenging radicals with urocanic acid, derivatives and analogues |
| 04/17/2002 | EP1196083A1 Imaging the dopamine transporter to determine ad-hd |
| 04/17/2002 | EP1196050A1 Compositions, kits, and methods for providing and maintaining energy and mental alertness |
| 04/17/2002 | EP1196047A1 Prophylactic dietary supplement based on milk |
| 04/17/2002 | EP1196046A1 Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise |
| 04/17/2002 | EP1196034A1 Antiparasitic formulation |
| 04/17/2002 | EP1152755B1 Essential fatty acids in the prevention of cardiovascular events |
| 04/17/2002 | EP1112079B1 Myrtle extract, preparation method and use |
| 04/17/2002 | EP1095037B1 process of synthesis of 5-methoxy- 2- (4-methoxy- 3,5-dimethyl- 2-pyridyl)methyl]sulfinyl-1h-benzimidazole |
| 04/17/2002 | EP1042322B1 Kv2.1 ANTAGONISTS |
| 04/17/2002 | EP1033991B1 Mometasone furoate suspensions for nebulization |
| 04/17/2002 | EP1033962B1 Reduction of hair growth |
| 04/17/2002 | EP1028730B1 Compositions of lipid lowering agents |
| 04/17/2002 | EP1019037B9 Medicament containing delta-aminolevulinic acid |
| 04/17/2002 | EP0998475B1 Novel compounds |
| 04/17/2002 | EP0996620B1 Novel compounds |
| 04/17/2002 | EP0970103B1 Antigestagenic steroids with a fluorinated 17alpha-alkyl chain |
| 04/17/2002 | EP0968212B1 Method of making (1s, 4r)-1-azabicyclo 2.2.1]heptan-3-one and (1r, 4s), 1-azabicyclo 2.2.1]heptan-3-one |
| 04/17/2002 | EP0956285B1 Novel genipin derivative having anti hepatitis b virus activity |
| 04/17/2002 | EP0956010B1 Pharmaceutical microspheres of valproic acid for oral administration |
| 04/17/2002 | EP0937038B1 Vitamin d analogues |
| 04/17/2002 | EP0934290B1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 04/17/2002 | EP0915702B1 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| 04/17/2002 | EP0912086A4 Regulation of alzheimer's disease related proteins and uses thereof |
| 04/17/2002 | EP0906127B1 Novel devices for transdermal administering of trimegestone |
| 04/17/2002 | EP0902783B1 Hydrolysis-promoting taxane hydrophobic derivatives |
| 04/17/2002 | EP0901378B1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid |
| 04/17/2002 | EP0888313B1 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 04/17/2002 | EP0880519B1 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them |
| 04/17/2002 | EP0876152B1 Novel administration of thrombopoietin |
| 04/17/2002 | EP0873129B1 Anion exchange resin-containing tablets |
| 04/17/2002 | EP0866699B1 The use of cholinesterase inhibitors for the manufacture of a medicament for the treatment of xerostomia |
| 04/17/2002 | EP0863767B1 Powdery iodine complexes |
| 04/17/2002 | EP0857062B1 Method of producing multi-layer medicaments in solid form for oral or rectal administration |
| 04/17/2002 | EP0851762B1 Pharmaceutical combination preparations containing erythropoietin and iron preparations |
| 04/17/2002 | EP0837684B1 Pharmaceutical compositions containing a diclofenac salt and thiocolchicoside |
| 04/17/2002 | EP0831911B1 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |